Skip to main content
. 2018 Mar 14;11:1413–1422. doi: 10.2147/OTT.S151286

Table 2.

Correlations between histological characteristics of melanoma primary tumors and FOXP1 expression in neoplastic and stromal compartments

Histopathological parameters FOXP1 immunoreactivity
Tumor cells
Stromal cells
Low (n=54) High (n=42) p-value Absent (n=18) Present (n=78) p-value
Breslow thickness (mm) 1.20 (0.70–4.00) 2.50 (1.20–4.00) 0.0649a 3.85 (2.00–6.00) 1.80 (0.75–4.00) 0.0021a
Clark level
 I 0 (0.00) 0 (0.00) 0.0529b 0 (0.00) 0 (0.00) 0.0112b
 II 14 (25.93) 3 (7.14) 2 (11.11) 15 (19.23)
 III 24 (44.44) 22 (52.38) 5 (27.78) 41 (52.56)
 IV 12 (22.22) 12 (28.57) 7 (38.89) 17 (21.79)
 V 4 (7.41) 5 (11.90) 4 (22.22) 5 (6.41)
Histological type
 Superficial spreading melanoma 38 (70.37) 26 (61.90) 0.5673c 9 (50.00) 55 (70.51) 0.2601c
 Nodular malignant melanoma 14 (25.93) 15 (35.71) 8 (44.44) 21 (26.92)
 Acral lentiginous melanoma 2 (3.70) 1 (2.38) 1 (5.56) 2 (2.56)
Mitotic rate
 0 28 (51.85) 16 (38.10) 0.1796d 5 (27.78) 39 (50.00) 0.1171e
 ≥1 26 (48.15) 26 (61.90) 13 (72.22) 39 (50.00)
Ulceration
 No 34 (62.96) 18 (42.86) 0.0640e 5 (27.78) 47 (60.26) 0.0177e
 Yes 20 (37.04) 24 (57.14) 13 (72.22) 31 (39.74)
TILs
 No 8 (14.81) 9 (21.43) 0.2533c 4 (22.22) 13 (16.67) 0.5749c
 Nonbrisk 15 (27.78) 16 (38.10) 7 (38.89) 24 (30.77)
 Brisk 31 (57.41) 17 (40.48) 7 (38.89) 41 (52.56)
Microsatellitosis
 No 50 (92.59) 41 (97.62) 0.3818e 16 (88.89) 75 (96.15) 0.2346e
 Yes 4 (7.41) 1 (2.38) 2 (11.11) 3 (3.85)
Tumor regression
 No 52 (96.30) 37 (88.10) 0.2340e 15 (83.33) 74 (94.87) 0.1195e
 Yes 2 (3.70) 5 (11.90) 3 (16.67) 4 (5.13)

Notes: Data presented as median (1: quartile–3: quartile) or n (%).

a

p-value of the Mann–Whitney U-test;

b

p-value of the Cochran–Armitage test for trend;

c

p-value of the Freeman–Halton extension of the Fisher’s exact probability test;

d

p-value of the Pearson’s χ2 test;

e

p-value of the Fisher’s exact test; statistically significant results (p<0.05) are given in bold.

Abbreviation: TILs, tumor-infiltrating lymphocytes.